Home・Aandelen Lijst・Quest Diagnostics Inc

Quest Diagnostics Inc

Gesloten

SectorGezondheidszorg

234.85 -0.1

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

228.1

Max

235.41

Belangrijke statistieken
By Trading Economics
Inkomsten	70M 334M
Verkoop	148M 3B
K/W Sectorgemiddelde	24.638 64.641
EPS	3.12
Dividendrendement	1.46
Winstmarge	10.976
Werknemers	46,000
EBITDA	47M 481M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+7.43% upside

Dividenden
By Acuity
Dividendrendement Sectorgemiddelde	1.46% 2.31%
Volgende Winsten	20 okt 2026
Volgende dividenddatum	19 okt 2026
Volgende Ex Dividend datum	2 okt 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	2.6B 26B
Vorige openingsprijs	234.95
Vorige sluitingsprijs	234.85

Nieuwssentiment

By Acuity

31%

69%

86 / 340 Rangschikking in Healthcare

Quest Diagnostics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

29 jul 2026, 20:08 UTC

Correlated Moves

Quest Diagnostics shares are lower amid a broader decline in the Health Care Services sub-sector, reflecting a negative trend seen since Tuesday's close.

28 jul 2026, 23:01 UTC

Quest Diagnostics Inc shares are higher in after-market trading, maintaining upward momentum amid broader market strength and trading above their 20-day moving average.

27 jul 2026, 17:26 UTC

News

Quest Diagnostics Inc. shares are higher today, supported by a 10% revenue increase to $3 billion for Q2 and an improved full-year outlook.

24 jul 2026, 21:21 UTC

Quest Diagnostics Inc shares are higher in after-market hours, continuing a trend of gains over the past three sessions. No specific news was identified.

23 jul 2026, 10:01 UTC

Quest Diagnostics Inc is higher in pre-market hours, continuing gains from Wednesday's strong performance, despite an earlier pullback during the session.

22 jul 2026, 23:26 UTC

Quest Diagnostics Inc shares rose in after-market trading, reflecting a notable increase since Wednesday's close amid broader market volatility from geopolitical tensions.

21 jul 2026, 19:46 UTC

Correlated Moves

Quest Diagnostics Inc shares are lower today, following declines in Labcorp Holdings Inc, which may be impacting overall sentiment for the stock.

20 jul 2026, 23:02 UTC

Quest Diagnostics Inc shares are lower in after-market hours, with no specific news identified to explain the decline. The stock is below its 20-day moving average.

Peer Vergelijking

Prijswijziging

Quest Diagnostics Inc Prognose

Koersdoel

By TipRanks

7.43% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 252.7 USD 7.43%

Hoogste 265 USD

Laagste 232 USD

Gebaseerd op 11 Wall Street-analisten die 12-maands prijsdoelen bieden voor Quest Diagnostics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

11 ratings

Buy

Hold

Sell

Gebaseerd op 11 analisten die aandelenratings hebben gegeven aan Quest Diagnostics Inc - Dist in de afgelopen 3 maanden.

Sentiment

By Acuity

86 / 340 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Quest Diagnostics Inc

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.